The Enterprise Value as of September 2024 (TTM) for BiondVax Pharmaceuticals Ltd. (BVXV) is 22.07M

According to BiondVax Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 22.07M. This represents a change of -100.00% compared to the average of 558.05B of the last 4 quarters.

BiondVax Pharmaceuticals Ltd. (BVXV) Historical Enterprise Value (quarterly & annually)

How has BVXV Enterprise Value performed in the past?

The mean historical Enterprise Value of BiondVax Pharmaceuticals Ltd. over the last ten years is 223.29B. The current 22.07M Enterprise Value has changed -99.01% with respect to the historical average. Over the past ten years (40 quarters), BVXV's Enterprise Value was at its highest in in the December 2022 quarter at 2.23T. The Enterprise Value was at its lowest in in the December 2013 quarter at -17863000.00.

BiondVax Pharmaceuticals Ltd. (BVXV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BiondVax Pharmaceuticals Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BiondVax Pharmaceuticals Ltd. (BVXV) Average Enterprise Value

How has BVXV Enterprise Value performed in the past?

The current Enterprise Value of BiondVax Pharmaceuticals Ltd. (BVXV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BiondVax Pharmaceuticals Ltd. (BVXV) Enterprise Value vs. Peers

How is BVXV’s Enterprise Value compared to its peers?

BiondVax Pharmaceuticals Ltd.’s Enterprise Value is greater than First Wave BioPharma, Inc. (9.55M), greater than Salarius Pharmaceuticals, Inc. (-721970.00), greater than SAB Biotherapeutics, Inc. (11.73M), greater than Vaccinex, Inc. (8.80M), greater than GeoVax Labs, Inc. (21.51M), greater than Molecular Partners AG (-19524916.95), less than Mineralys Therapeutics, Inc. (513.45M), greater than AN2 Therapeutics, Inc. (4.86M), less than Pharvaris N.V. (643.57M), less than PepGen Inc. (255.11M), greater than Can-Fite BioPharma Ltd. (11.60M), less than Oramed Pharmaceuticals Inc. (169.20M), less than MediWound Ltd. (193.58M), less than BioLineRx Ltd. (74.43M), greater than Surrozen, Inc. (-9920141.00), less than Armata Pharmaceuticals, Inc. (195.72M), greater than Pasithea Therapeutics Corp. (-1911899.00), greater than Oncternal Therapeutics, Inc. (-1263577.00), greater than Aditxt, Inc. (9.56M), greater than Adial Pharmaceuticals, Inc. (3.63M), greater than TransCode Therapeutics, Inc. (2.92M), less than Reviva Pharmaceuticals Holdings, Inc. (40.92M), greater than Avenue Therapeutics, Inc. (-1054328.00),

Build a custom stock screener for BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiondVax Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BiondVax Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.